Tracing mutation patterns and molecular changes to link environmental contamination to cancer

Project 2: High Resolution Mutation Spectra and Multi-Omics for Deducing Etiology and Predicting Disease

NIH-funded research Massachusetts Institute of Technology · NIH-11126762

The team uses detailed genetic and molecular tests to see whether chemical pollution near Superfund sites causes DNA damage that could raise cancer risk for exposed communities.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMassachusetts Institute of Technology NIH-funded
Lab location1 site (Cambridge, United States)
Project IDNIH-11126762 on NIH RePORTER

What this research studies

From where I stand, researchers are working with communities near Superfund sites to focus on chemicals such as N-nitrosamines that may harm DNA. They combine a specially engineered panel of mice that reveal susceptibility pathways with very high-fidelity DNA sequencing and other 'multi-omics' lab tests to map mutations and protein changes. The project ties those detailed laboratory findings back to exposure patterns in the local catchment areas, including engagement with tribal groups in Maine. Together, the approach aims to build biological links between environmental contamination and disease processes like cancer.

Who could benefit from this research

Good fit: People who live or have lived near Superfund or contaminated sites, especially those with known exposure to chemicals like NDMA or concerns about cancer risk, are the most relevant candidates for this work.

Not a fit: Patients with health issues unrelated to environmental exposures or who have no history of living near contaminated sites are unlikely to benefit directly from this project.

Why it matters

Potential benefit: If successful, this work could show how specific environmental chemicals cause DNA damage and cancer risk, helping communities, doctors, and regulators prevent exposure and target screening.

How similar studies have performed: Previous laboratory studies have shown that agents like NDMA can damage DNA, but applying ultra-accurate sequencing and integrated multi-omics to directly link environmental exposures to human cancer risk is relatively new.

Where this research is happening

Cambridge, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancers
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.